E M Levy1, C M Viscoli, R I Horwitz. 1. Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn, USA.
Abstract
OBJECTIVE: To determine if the high mortality in acute renal failure is explained by underlying illnesses (comorbidity). DESIGN: Cohort analytic study. SETTING: An 826-bed general hospital providing primary, secondary, and tertiary care. PATIENTS: From 16,248 inpatients undergoing radiocontrast procedures between 1987 and 1989, we identified 183 index subjects who developed contrast media-associated renal failure (defined as an increase in serum creatinine level of at least 25%, to at least 177 micromol/L [2 mg/dL], within 2 days of receiving contrast material) and 174 paired subjects, matched for age and baseline serum creatinine level, who underwent similar contrast procedures without developing renal failure. MAIN OUTCOME MEASURE: Death during hospitalization. RESULTS: The mortality rate in subjects without renal failure was 7%, compared with 34% in the corresponding index subjects with renal failure (odds ratio, 6.5; P<.001). After adjusting for differences in comorbidity, renal failure was associated with an odds ratio of dying of 5.5. Subjects who died after developing renal failure had complicated clinical courses characterized by sepsis, bleeding, delirium, and respiratory failure; most of these complications developed after the onset of renal failure. Deaths from renal causes were rare. CONCLUSIONS: The high mortality rate in acute renal failure is not explained by the underlying conditions alone. Renal failure appears to increase the risk of developing severe nonrenal complications that lead to death and should not be regarded as a treatable complication of serious illness.
OBJECTIVE: To determine if the high mortality in acute renal failure is explained by underlying illnesses (comorbidity). DESIGN: Cohort analytic study. SETTING: An 826-bed general hospital providing primary, secondary, and tertiary care. PATIENTS: From 16,248 inpatients undergoing radiocontrast procedures between 1987 and 1989, we identified 183 index subjects who developed contrast media-associated renal failure (defined as an increase in serum creatinine level of at least 25%, to at least 177 micromol/L [2 mg/dL], within 2 days of receiving contrast material) and 174 paired subjects, matched for age and baseline serum creatinine level, who underwent similar contrast procedures without developing renal failure. MAIN OUTCOME MEASURE: Death during hospitalization. RESULTS: The mortality rate in subjects without renal failure was 7%, compared with 34% in the corresponding index subjects with renal failure (odds ratio, 6.5; P<.001). After adjusting for differences in comorbidity, renal failure was associated with an odds ratio of dying of 5.5. Subjects who died after developing renal failure had complicated clinical courses characterized by sepsis, bleeding, delirium, and respiratory failure; most of these complications developed after the onset of renal failure. Deaths from renal causes were rare. CONCLUSIONS: The high mortality rate in acute renal failure is not explained by the underlying conditions alone. Renal failure appears to increase the risk of developing severe nonrenal complications that lead to death and should not be regarded as a treatable complication of serious illness.
Authors: Kashyap Patel; Jason A Roberts; Jeffrey Lipman; Susan E Tett; Megan E Deldot; Carl M Kirkpatrick Journal: Antimicrob Agents Chemother Date: 2011-09-19 Impact factor: 5.191
Authors: Paolo Calabrò; Renatomaria Bianchi; Mario Crisci; Mario Caprile; Maurizio Cappelli Bigazzi; Rosalinda Palmieri; Enrica Golia; Anna De Vita; Ilaria Jane Romano; Giuseppe Limongelli; Maria Giovanna Russo; Raffaele Calabrò Journal: Intern Emerg Med Date: 2011-01-29 Impact factor: 3.397
Authors: Eric A J Hoste; Severine Doom; Jan De Waele; Louke J Delrue; Luc Defreyne; Dominique D Benoit; Johan Decruyenaere Journal: Intensive Care Med Date: 2011-11-03 Impact factor: 17.440
Authors: Jason A Roberts; Jonathan Field; Adam Visser; Rosemary Whitbread; Mandy Tallot; Jeffrey Lipman; Carl M J Kirkpatrick Journal: Antimicrob Agents Chemother Date: 2010-06-14 Impact factor: 5.191